{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:10:54Z","timestamp":1760825454548,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jocn.2022.05.031","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T02:43:21Z","timestamp":1654483401000},"page":"5-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Meaningful use of imaging resources to rule out cerebral venous sinus thrombosis after ChAdOx1 COVID-19 vaccination: Evaluation of the AHA diagnostic algorithm with a clinical cohort and a systematic data review"],"prefix":"10.1016","volume":"102","author":[{"given":"Philipp","family":"Fervers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Kottlors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Persigehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Lennartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Maus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Styczen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius","family":"Deuschl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Schlamann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Mpotsaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seraphine","family":"Zubel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Maintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gereon Rudolf","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuran","family":"Abdullayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.jocn.2022.05.031_b0005","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1016\/j.vaccine.2020.10.059","article-title":"The public\u2019s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States","volume":"39","author":"Schoch-Spana","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jocn.2022.05.031_b0010","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","article-title":"COVID-19 vaccines: where we stand and challenges ahead","volume":"28","author":"Forni","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jocn.2022.05.031_b0015","unstructured":"COVID-19 Vaccines | FDA n.d. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/covid-19-vaccines (accessed March 18, 2021)."},{"key":"10.1016\/j.jocn.2022.05.031_b0020","unstructured":"COVID-19 vaccines: authorised | European Medicines Agency n.d. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/vaccines-covid-19\/covid-19-vaccines-authorised#authorised-covid-19-vaccines-section (accessed March 18, 2021)."},{"key":"10.1016\/j.jocn.2022.05.031_b0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/d41586-021-00140-w","article-title":"Are COVID vaccination programmes working? Scientists seek first clues","volume":"589","author":"Mallapaty","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jocn.2022.05.031_b0030","unstructured":"Paul-Ehrlich-Institut - Suspension Vaccination AstraZeneca n.d. https:\/\/www.pei.de\/EN\/service\/faq\/coronavirus\/faq-coronavirus-node.html;jsessionid=6884835C299C471D7857505ABF63DE45.intranet241?cms_tabcounter=3 (accessed March 18, 2021)."},{"issue":"22","key":"10.1016\/j.jocn.2022.05.031_b0035","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2022.05.031_b0040","unstructured":"AstraZeneca\u2019s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets | European Medicines Agency n.d. https:\/\/www.ema.europa.eu\/en\/news\/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood (accessed April 13, 2021)."},{"issue":"03","key":"10.1016\/j.jocn.2022.05.031_b0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/a-1469-7481","article-title":"Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH","volume":"41","author":"Oldenburg","year":"2021","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jocn.2022.05.031_b0050","unstructured":"Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine | FDA n.d. https:\/\/www.fda.gov\/news-events\/press-announcements\/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine (accessed April 15, 2021)."},{"key":"10.1016\/j.jocn.2022.05.031_b0055","article-title":"Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT)","volume":"5","author":"Makris","year":"2021","journal-title":"Wiley"},{"issue":"10","key":"10.1016\/j.jocn.2022.05.031_b0060","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.7326\/L21-0244","article-title":"Thrombosis With Thrombocytopenia After the Messenger RNA\u20131273 Vaccine","volume":"174","author":"Sangli","year":"2021","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jocn.2022.05.031_b0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/vaccines9060673","article-title":"Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States","volume":"9","author":"Riad","year":"2021","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.jocn.2022.05.031_b0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.jocn.2022.05.031_b0075","first-page":"3045","volume":"52","author":"Siegler","year":"2021","journal-title":"Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia"},{"key":"10.1016\/j.jocn.2022.05.031_b0080","unstructured":"Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 July 2021 | European Medicines Agency n.d. https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-july-2021 (accessed July 23, 2021)."},{"key":"10.1016\/j.jocn.2022.05.031_b0085","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372. https:\/\/doi.org\/10.1136\/BMJ.N71.","DOI":"10.1136\/bmj.n71"},{"issue":"8","key":"10.1016\/j.jocn.2022.05.031_b0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14760584.2021.1940145","article-title":"Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)","volume":"20","author":"Esba","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.jocn.2022.05.031_b0095","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/bloodadvances.2021004904","article-title":"A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2","volume":"5","author":"T\u00f8lb\u00f8ll S\u00f8rensen","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jocn.2022.05.031_b0100","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2022.05.031_b0105","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/jcm10081599","article-title":"Thrombocytopenia and Intracranial Venous Sinus Thrombosis after \u201cCOVID-19 Vaccine AstraZeneca\u201d Exposure","volume":"10","author":"Wolf","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jocn.2022.05.031_b0110","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccine","author":"Tiede","year":"2021","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jocn.2022.05.031_b0115","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Brief Report: Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.jocn.2022.05.031_b0120","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2022.05.031_b0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbi.2021.04.006","article-title":"Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination \u2013 A report of two UK cases","volume":"95","author":"Mehta","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jocn.2022.05.031_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-021-03572-y","article-title":"Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19","volume":"25","author":"Castelli","year":"2021","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.jocn.2022.05.031_b0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/jpm11040285","article-title":"A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration","volume":"11","author":"D\u2019Agostino","year":"2021","journal-title":"J Pers Med"},{"issue":"7","key":"10.1016\/j.jocn.2022.05.031_b0140","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s00134-021-06425-y","article-title":"Fatal cerebral venous sinus thrombosis after COVID-19 vaccination","volume":"47","author":"Jamme","year":"2021","journal-title":"Intensive Care Med"},{"issue":"10306","key":"10.1016\/j.jocn.2022.05.031_b0145","first-page":"1147","article-title":"Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study","volume":"398","author":"Perry","year":"2021","journal-title":"WwwThelancetCom"},{"key":"10.1016\/j.jocn.2022.05.031_b0150","doi-asserted-by":"crossref","first-page":"427.e3","DOI":"10.1016\/j.ajem.2021.07.011","article-title":"A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination","volume":"51","author":"Guan","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jocn.2022.05.031_b0155","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.279246","article-title":"Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia","author":"Bonato","year":"2021","journal-title":"Haematologica"},{"issue":"31","key":"10.1016\/j.jocn.2022.05.031_b0160","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e223","article-title":"Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea","volume":"36","author":"Choi","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jocn.2022.05.031_b0165","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3389\/fneur.2021.721146","article-title":"Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series","volume":"12","author":"Wiedmann","year":"2021","journal-title":"Front Neurol"},{"issue":"18","key":"10.1016\/j.jocn.2022.05.031_b0170","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2022.05.031_b0175","doi-asserted-by":"crossref","unstructured":"Bano F, Badugama B, Chandra D. Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience. BMJ Case Rep 2021;14:243894. https:\/\/doi.org\/10.1136\/BCR-2021-243894.","DOI":"10.1136\/bcr-2021-243894"},{"issue":"4","key":"10.1016\/j.jocn.2022.05.031_b0180","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/svn-2021-001095","article-title":"Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan","volume":"6","author":"Ikenberg","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.jocn.2022.05.031_b0185","doi-asserted-by":"crossref","unstructured":"Thakur KT, Tamborska A, Wood GK, McNeill E, Roh D, Akpan IJ, et al. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions. J Neurol Sci 2021;427:117532. https:\/\/doi.org\/10.1016\/J.JNS.2021.117532.","DOI":"10.1016\/j.jns.2021.117532"},{"key":"10.1016\/j.jocn.2022.05.031_b0190","unstructured":"German Ministry of Health. Vaccination with AstraZeneca | FAQ n.d. https:\/\/www.bundesgesundheitsministerium.de\/coronavirus\/faq-covid-19-impfung\/faq-impfung-astrazeneca.html#c20802 (accessed March 21, 2021)."},{"key":"10.1016\/j.jocn.2022.05.031_b0195","unstructured":"Thrombosef\u00e4lle nach Astrazeneca-Impfung: Impfstopp ist umstritten n.d. https:\/\/www.aerzteblatt.de\/nachrichten\/122083\/Thrombosefaelle-nach-Astrazeneca-Impfung-Impfstopp-ist-umstritten (accessed March 19, 2021)."},{"key":"10.1016\/j.jocn.2022.05.031_b0200","unstructured":"Coronavirus vaccine - weekly summary of Yellow Card reporting - GOV.UK n.d. https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting (accessed March 18, 2021)."},{"key":"10.1016\/j.jocn.2022.05.031_b0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/pmj.76.891.12","article-title":"Cerebral venous sinus thrombosis","volume":"76","author":"Allroggen","year":"2000","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.jocn.2022.05.031_b0210","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.15341","article-title":"Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology","volume":"19","author":"Nazy","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jocn.2022.05.031_b0215","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.jocn.2022.05.031_b0220","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamaneurol.2021.3619","article-title":"Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia","volume":"78","author":"S\u00e1nchez van Kammen","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2022.05.031_b0225","doi-asserted-by":"crossref","unstructured":"Potteg\u00e5rd A, Lund LC, Karlstad \u00d8, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ 2021;373. https:\/\/doi.org\/10.1136\/BMJ.N1114.","DOI":"10.1136\/bmj.n1114"},{"key":"10.1016\/j.jocn.2022.05.031_b0230","doi-asserted-by":"crossref","unstructured":"Krzywicka K, van de Munckhof A, Van Kammen MS, Heldner MR, Jood K, Lindgren E, et al. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination. Neurology 98:e759\u201368. https:\/\/doi.org\/10.1212\/WNL.0000000000013148.","DOI":"10.1212\/WNL.0000000000013148"},{"key":"10.1016\/j.jocn.2022.05.031_b0235","unstructured":"German Society for Hematology and Medical Oncology: AstraZeneca COVID-19 vaccine Managing the risk of coagulation complications n.d. moz-extension:\/\/11cd4625-89d6-437c-afa2-4c7fa509ef7e\/enhanced-reader.html?openApp&pdf=https%3A%2F%2Fwww.dgho.de%2Fpublikationen%2Fstellungnahmen%2Fgute-aerztliche-praxis%2Fcoronavirus%2Fastrazeneca-vakzine-gerinnungsstoerungen-20210319.pdf (accessed March 22, 2021)."},{"key":"10.1016\/j.jocn.2022.05.031_b0240","unstructured":"COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets | European Medicines Agency n.d. https:\/\/www.ema.europa.eu\/en\/news\/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots (accessed March 19, 2021)."},{"issue":"10283","key":"10.1016\/j.jocn.2022.05.031_b0245","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(21)00762-5","article-title":"Thromboembolism and the Oxford\u2013AstraZeneca COVID-19 vaccine: side-effect or coincidence?","volume":"397","author":"\u00d8stergaard","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2022.05.031_b0250","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.diii.2014.10.006","article-title":"Imaging of cerebral venous thrombosis","volume":"95","author":"Bonneville","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jocn.2022.05.031_b0255","doi-asserted-by":"crossref","unstructured":"Fervers P, Kottlors J, Maus V, Sebastian F, Styczen H, Deuschl C, et al. Imaging of Neurologically Symptomatic Patients after AZD1222 (Astrazeneca\u00ae) Vaccination \u2013 a Multicenter Study of 28 Cases. SSRN Electron J 2021. https:\/\/doi.org\/10.2139\/SSRN.3812431.","DOI":"10.2139\/ssrn.3812431"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822002454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822002454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:30:15Z","timestamp":1760823015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822002454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":51,"alternative-id":["S0967586822002454"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.05.031","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meaningful use of imaging resources to rule out cerebral venous sinus thrombosis after ChAdOx1 COVID-19 vaccination: Evaluation of the AHA diagnostic algorithm with a clinical cohort and a systematic data review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}